Directors of Neimeth International Pharmaceuticals Plc have expressed determination to grow the turnover of the company to the N4 billion mark in the immediate future.
At the annual general meeting in Lagos, shareholders unanimously approved the balance sheet restructuring that enables the compan
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
